Literature DB >> 17108242

A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.

Elizabeth Dale1, Miriam Davis, Denise L Faustman.   

Abstract

Sex hormones have long been implicated in autoimmune diseases because women account for 80% of cases. The mechanism of hormonal action in autoimmunity is unknown. Drawing on genetic studies of autoimmune disease, this article discusses how both genes and sex hormones may exert their effects through the same general mechanism, dysregulation of transcription factor NF-kappaB, an immunoregulatory protein. Gene and hormone alterations of the NF-kappaB signaling cascade provide a unifying hypothesis to explain the wide-ranging human and murine autoimmune disease phenotypes regulated by NF-kappaB, including cytokine balance, antigen presentation, lymphoid development, and lymphoid repertoire selection by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108242     DOI: 10.1152/advan.00065.2006

Source DB:  PubMed          Journal:  Adv Physiol Educ        ISSN: 1043-4046            Impact factor:   2.288


  19 in total

1.  Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans.

Authors:  Fatima Iqbal; William J Durham; Ayyash Melhem; Saleem Raslan; Tony T Tran; Traver J Wright; Rabia Asghar; Ken Fujise; Elena Volpi; Labros Sidossis; Nicola Abate; Melinda Sheffield-Moore; Demidmaa Tuvdendorj
Journal:  Int J Dev Neurosci       Date:  2017-07-12       Impact factor: 2.457

2.  Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Dario Domenico Lofrumento; Giuseppe Ingravallo; Raffaella De Lucro; Massimo D'Amore
Journal:  J Mol Histol       Date:  2013-02-03       Impact factor: 2.611

3.  Modulation of gene expression regulated by the transcription factor NF-κB/RelA.

Authors:  Xueling Li; Yingxin Zhao; Bing Tian; Mohammad Jamaluddin; Abhishek Mitra; Jun Yang; Maga Rowicka; Allan R Brasier; Andrzej Kudlicki
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

4.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

5.  NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack.

Authors:  Yiqun Du; Xiaoyan Teng; Na Wang; Xin Zhang; Jianfeng Chen; Peipei Ding; Qian Qiao; Qingkai Wang; Long Zhang; Chaoqun Yang; Zhangmin Yang; Yiwei Chu; Xiang Du; Xuhui Zhou; Weiguo Hu
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

6.  Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells.

Authors:  Abigail Peairs; Rujuan Dai; Lu Gan; Samuel Shimp; M Nichole Rylander; Liwu Li; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

7.  I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.

Authors:  Chia-Hui Lin; Shu-Chen Wang; Tsan-Teng Ou; Ruei-Nian Li; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

8.  Effect of oophorectomy and exogenous estrogen replacement on liver injury in experimental obstructive jaundice.

Authors:  Hamdi Bulent Ucan; Mehmet Kaplan; Bulent Salman; Utku Yilmaz; B-Bulent Mentes; Cemalettin Aybay
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

9.  EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop?

Authors:  Denise L Faustman
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

10.  IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.

Authors:  Tsan-Teng Ou; Chia-Hui Lin; Yu-Chih Lin; Ruei-Nian Li; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2008-07-04       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.